Close Menu

NEW YORK – Redwood City, California-based Revolution Medicines on Wednesday after the close of the market said it would offer 5,797,101 shares of its common stock at an offering price of $45 per share.

Additionally, the company has offered underwriters a 30-day option to purchase an additional 869,565 shares of common stock at the public offering price. The precision oncology-focused firm is expecting the offering to bring in gross proceeds of around $260.9 million, not factoring in the underwriters' option to purchase additional shares.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.